We are live on
!
Find out more
DnB Asset Management Portfolio holdings
AUM
$28B
1-Year Est. Return
26%
This Fund
S&P 500
This Quarter
Est. Return
+6.47%
1 Year Est. Return
+26%
3 Year Est. Return
+97.1%
5 Year Est. Return
+115.87%
10 Year Est. Return
+443.63%
AUM
$3.65B
AUM Growth
+$274M
(+8.1%)
Cap. Flow
+$84.1M
Cap. Flow
% of AUM
2.3%
Top 10 Holdings %
Top 10 Hldgs %
28.53%
Holding
425
New
46
Increased
147
Reduced
190
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
eBay
EBAY
|
+$97.5M |
| 2 |
Corning
GLW
|
+$58.4M |
| 3 |
Medtronic
MDT
|
+$55.8M |
| 4 |
AGN
Allergan Inc
AGN
|
+$48.5M |
| 5 |
Quanta Services
PWR
|
+$48.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$51.7M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$43.8M |
| 3 |
Veeco
VECO
|
+$43.7M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$43.3M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$40.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.65% |
| 2 | Financials | 14.86% |
| 3 | Healthcare | 11.85% |
| 4 | Industrials | 11.51% |
| 5 | Consumer Discretionary | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Flowserve
FLS
$9.25B
| $984K | 0.03% |
15,765
-2,100
| -12% | -$121K |
|
252
ICICI Bank
IBN
$106B
| $966K | 0.03% |
174,350
+113,850
| +188% | +$668K |
|
253
TJX Companies
TJX
$170B
| $959K | 0.03% |
34,020
+4,800
| +16% | +$128K |
|
254
Brown-Forman Class B
BF.B
$12B
| $959K | 0.03% |
+43,972
| New | +$991K |
|
255
T-Mobile US
TMUS
$193B
| $957K | 0.03% |
36,865
+2,900
| +9% | +$70.9K |
|
256
Fidelity National Financial
FNF
$13.9B
| $939K | 0.03% |
+61,829
| New | +$871K |
|
257
Thermo Fisher Scientific
TMO
$211B
| $922K | 0.03% |
+10,008
| New | +$905K |
|
|
YHOO
258
DELISTED
Yahoo Inc
YHOO
| $920K | 0.03% |
27,750
-1,549,037
| -98% | -$43.8M |
|
|
PARA
259
DELISTED
Paramount Global Class B
PARA
| $914K | 0.03% |
16,562
-4,700
| -22% | -$250K |
|
|
CSC
260
DELISTED
Computer Sciences
CSC
| $902K | 0.02% |
41,359
-7,119
| -15% | -$150K |
|
261
American Tower
AMT
$77.7B
| $897K | 0.02% |
12,102
+1,300
| +12% | +$93.8K |
|
262
PLDT
PHI
$4.25B
| $895K | 0.02% |
13,200
-1,900
| -13% | -$128K |
|
263
Exelon
EXC
$48.6B
| $893K | 0.02% |
42,255
-2,383
| -5% | -$52.1K |
|
264
Tyson Foods
TSN
$20.2B
| $890K | 0.02% |
31,458
-28,900
| -48% | -$838K |
|
265
Lincoln National
LNC
$7.91B
| $884K | 0.02% |
21,050
+700
| +3% | +$29.5K |
|
266
MidCap Financial Investment
MFIC
$784M
| $883K | 0.02% |
36,130
+133
| +0.4% | +$3.23K |
|
267
Turkcell
TKC
$4.84B
| $865K | 0.02% |
58,670
-8,500
| -13% | -$123K |
|
268
Baxter International
BAX
$11.6B
| $859K | 0.02% |
24,064
+3,498
| +17% | +$136K |
|
269
Hexcel
HXL
$8.32B
| $858K | 0.02% |
22,100
| – | – |
|
|
CFN
270
DELISTED
CAREFUSION CORPORATION
CFN
| $845K | 0.02% |
22,908
-4,900
| -18% | -$183K |
|
271
Stryker
SYK
$127B
| $845K | 0.02% |
12,495
-5,800
| -32% | -$400K |
|
272
Annaly Capital Management
NLY
$16.9B
| $825K | 0.02% |
17,812
-11,425
| -39% | -$538K |
|
273
Universal Health Services
UHS
$9.43B
| $817K | 0.02% |
+10,900
| New | +$760K |
|
274
Toll Brothers
TOL
$14B
| $813K | 0.02% |
+25,077
| New | +$811K |
|
275
Braskem
BAK
$980M
| $796K | 0.02% |
49,900
-45,600
| -48% | -$699K |
|
Similar funds
N
PCH
TWC
FDCDDQ
NA
DnB Asset Management's Q3 2013 Portfolio in Review
As of Q3 2013, DnB Asset Management held 425 positions worth $3.65B, up 8.1% from $3.38B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
DnB Asset Management's Q3 2013 filing shows 46 new, 147 increased, 190 reduced and 32 closed positions. Its largest new stake was Quanta Services: 1,776,500 shares worth $48.9M. The largest sale was Pfizer, an estimated $51.7M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- DnB Asset Management's largest Q3 2013 buy was Quanta Services: 1,776,500 shares worth $48.9M.
- DnB Asset Management added most to eBay in Q3 2013, an estimated $97.5M increase.
- DnB Asset Management's biggest Q3 2013 reduction was Pfizer, cutting an estimated $51.7M.
- DnB Asset Management fully exited Veeco in Q3 2013, selling an estimated $43.7M.
- DnB Asset Management's ten largest holdings make up 29% of its $3.65B portfolio in Q3 2013.
- DnB Asset Management opened 46 new positions and closed 32 in Q3 2013.
- DnB Asset Management's portfolio value rose 8.1% quarter-over-quarter to $3.65B.
Based on DnB Asset Management's 13F filing for Q3 2013, filed 17 Oct 2013.